. Author manuscript; available in PMC: 2023 Jan 10.

Published in final edited form as: Eur J Appl Physiol. 2022 Aug 12;122(11):2417–2426. doi: 10.1007/s00421-022-05022-1

Table 1.

Participant characteristics

	Statin n = 100	No statin n = 112	p
Age	69 ± 6	69 ± 6	0.68
Female, n (%)	51 (51%)	74 (66%)	0.03
Height, cm	170 ± 9	168 ± 10	0.13
Weight, kg	88 ± 18	84 ± 19	0.12
Body mass index, kg m⁻²	30 ± 5	30 ± 6	0.32
Heart rate, bpm	58 ± 7	57 ± 8	0.27
End-tidal CO₂, mmHg	35 ± 3	35 ± 4	0.93
sBP, mmHg	130 ± 15	132 ± 15	0.19
dBP, mmHg	73 ± 9	76 ± 9	0.08
MAP, mmHg	92 ± 10	95 ± 10	0.08
LDL-C, mg dL⁻¹	93 ± 29	119 ± 31	< 0.0001
HDL-C, mg dL⁻¹	53 ± 16	62 ± 20	< 0.001
Total cholesterol, mg dL⁻¹	170 ± 36	203 ± 37	< 0.0001
Beta-blocker, n (%)	75 (75%)	100 (89%)	< 0.01

Bold font indicates significance at p < 0.05

Continuous variables are mean ± standard deviation. Categorical variables are count (%)

dBP diastolic blood pressure, HDL-C high-density lipoprotein cholesterol, LDL-C low density lipoprotein cholesterol, MAP, mean arterial pressure, sBP systolic blood pressure